Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands.
作者:
主题词
抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);细胞周期(Cell Cycle);螯合剂(Chelating Agents);人类(Humans);半数抑制浓度(Inhibitory Concentration 50);铱(Iridium);配体(Ligands);溶酶体(Lysosomes);膜电位, 线粒体(Membrane Potential, Mitochondrial);NAD(NAD);有机化学品(Organic Chemicals);构效关系(Structure-Activity Relationship)
DOI
10.1016/j.jinorgbio.2018.11.007
PMID
30445339
发布时间
2019-12-17
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文